Abstract
Epidemiologic data have demonstrated that breast cancer incidence is inversely correlated with indices of vitamin D status, including ultraviolet exposure, which enhances epidermal vitamin D synthesis. The vitamin D receptor (VDR) is expressed in mammary epithelial cells, suggesting that vitamin D may directly influence sensitivity of the gland to transformation. Consistent with this concept, in vitro studies have demonstrated that the VDR ligand, 1,25-dihydroxyvitamin D (1, 25D), exerts negative growth regulatory effects on mammary epithelial cells that contribute to maintenance of the differentiated phenotype. Furthermore, deletion of the VDR gene in mice alters the balance between proliferation and apoptosis in the mammary gland, which ultimately enhances its susceptibility to carcinogenesis. In addition, dietary supplementation with vitamin D, or chronic treatment with synthetic VDR agonists, reduces the incidence of carcinogen-induced mammary tumors in rodents. Collectively, these observations have reinforced the need to further define the human requirement for vitamin D and the molecular actions of the VDR in relation to prevention of breast cancer.
Similar content being viewed by others
Article PDF
References
Holick MF . Vitamin D: A millenium perspective. J Cell Biochem 2003; 88: 296–307.
Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low Vitamin D Status Despite Abundant Sun Exposure. J Clin Endocrinol Metab 2007; in press.
Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ . Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004; 158: 531–7.
Hypponen E, Power C . Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860–8.
Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85: 649–50.
Zittermann A . Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutr 2003; 89: 552–72.
Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM . High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007; 137: 447–52.
Gonzalez G, Alvarado JN, Rojas A, Navarrete C, Velasquez CG, Arteaga E . High prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a worldwide concern. Menopause 2007; 14: 455–61.
Siddiqui AM, Kamfar HZ . Prevalence of vitamin D deficiency rickets in adolescent school girls in Western region, Saudi Arabia. Saudi Med J 2007; 28: 441–4.
Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P . 13th Workshop consensus for vitamin D nutritional guidelines. J Ster Biochem Mol Biol 2007; 103: 204–5.
Omdahl JL, Morris HA, May BK . Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002; 22: 139–66.
Hollis BW, Wagner CL, Drezner MK, Binkley NC . Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol 2007; 103: 631–4.
Kemmis CM, Salvador SM, Smith KM, Welsh J . Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr 2006; 136: 887–92.
Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, et al. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 2005; 11: 3579–86.
Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M . Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005; 97: 103–9.
Zinser GM, Welsh JE . Accelerated mammary gland development during pregnancy and delayed post-lactational involution in vitamin D3 receptor null mice. Mol Endocrinol 2004; 18: 2208–23.
Willnow TE, Nykjaer A . Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3. Curr Opin Lipidol 2002; 13: 255–60.
Norman AW . Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006; 147: 5542–8.
Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, et al. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res 1982; 42: 1116–9.
Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D . Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA micro-arrays. Prostate 2004; 59: 243–51.
Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, et al. Expression profiling in squamous carcinoma cells reveals pleio-tropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 2002; 16: 1243–56.
Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D . Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 2003; 80: 49–62.
Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M, Campbell MJ . Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 2006; 71: 111–23.
Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, et al. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol Rev 2006; 58: 742–59.
Carlberg C . Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 2003; 164: 29–42.
Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, et al. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem 1997; 66: 552–62.
Ellison TI, Eckert RL, MacDonald PN . Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. J Biol Chem 2007; 282: 10, 953–62.
Inoue T, Kamiyama J, Sakai T . Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 1999; 274: 32309–17.
Ellison TI, Dowd DR, MacDonald PN . Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription. Mol Endocrinol 2005; 19: 2309–19.
Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, et al. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J Cell Biochem 2002; 85: 435–57.
Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, Wurtz J, et al. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci USA 2004; 101: 12876–81.
Zanello LP, Norman AW . Rapid modulation of osteoblast ion channel responses by 1(alpha),25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 2004; 101: 12876–81.
Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW . The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1{alpha},25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 2004; 18: 2660–71.
Bettoun DJ, Buck DW, Lu J, Khalifa B, Chin WW, Nagpal S . A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J Biol Chem 2002; 277: 24847–50.
Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 2006; 21: 799–809.
Wali RK, Kong J, Sitrin MD, Bissonnette M, Li YC . Vitamin D receptor is not required for the rapid actions of 1,2 5 -dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J Cell Biochem 2003; 88: 794–801.
Khanal R, Nemere I . Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr 2007; 17: 31–47.
Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A . Vitamin D and cancer. J Steroid Biochem Mol Biol 2006; 102: 156–62.
Bouillon R, Verlinden L, Eelen G, De Clercq P, Vandewalle M, Mathieu C, et al. Mechanisms for the selective action of Vitamin D analogs. J Steroid Biochem Mol Biol 2005; 97: 21–30.
Mork-Hansen C, Binderup L, Hamberg KJ, Carlberg C . Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 2001; 6: D820–48.
Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, et al. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood 1996; 88: 2201–9.
Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY . Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. J Cell Physiol 1989; 138: 611–16.
Lazzaro G, Agadir A, Qing W, Poria M, Mehta RR, Moriarty RM, et al. Induction of differentiation by 1alpha-hydroxyvitamin D (5) in T47D human breast cancer cells and its interaction with vitamin D receptors. Eur J Cancer 2000; 36: 780–6.
Narvaez CJ, Welsh J . Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 2001; 276: 9101–7.
Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, et al. Vitamin D regulates the pheno-type of human breast cancer cells. Differentiation 2007; 75: 193–207.
Simboli-Campbell M, Narvaez CJ, vanWeelden K, Tenniswood M, Welsh J . Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 1997; 42: 31–41.
Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J . 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol 2001; 121: 103–9.
Wu G, Fan RS, Li W, Ko TC, Brattain MG . Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene 1997; 15: 1555–63.
Cordero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl PD, et al. 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem 2002; 277: 38965–71.
Kawata H, Kamiakito T, Takayashiki N, Tanaka A . Vitamin D3 suppresses the androgen-stimulated growth of mouse mammary carcinoma SC-3 cells by transcriptional repression of fibroblast growth factor 8. J Cell Physiol 2006; 207: 793–9.
Wu Y, Craig TA, Lutz WH, Kumar R . Identification of 1 alpha, 25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene. Biochemistry 1999; 38: 2654–60.
Xie SP, Pirianov G, Colston KW . Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur J Cancer 1999; 35: 1717–23.
Mathiasen IS, Lademann U, Jaattela M . Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res 1999; 59: 4848–56.
Chaudhry M, Sundaram S, Gennings C, Carter H, Gewirtz DA . The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells. Cancer Chemother Pharmacol 2001; 47: 429–36.
Posner GH, Crawford KR, Peleg S, Welsh JE, Romu S, Gewirtz DA, et al. A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin. Bioorg Med Chem 2001; 9: 2365–71.
Sundaram S, Gewirtz DA . The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation. Radiat Res 1999; 152: 479–86.
Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes PJ, Demidenko E, et al. The Combination of a Potent Vitamin D(3) Analog, EB 1089, with Ionizing Radiation Reduces Tumor Growth and Induces Apoptosis of MCF-7 Breast Tumor Xenografts in Nude Mice. Clin Cancer Res 2003; 9: 2350–6.
Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, Jaattela M . Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 2002; 277: 30738–45.
Hoyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jaattela M . Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 2005; 12: 1297–309.
Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J . 1, 25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 1996; 58: 367–76.
Valrance ME, Brunet AH, Acosta A, Welsh J . Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. J Cell Biochem 2007; in press.
Kommagani R, Caserta TM, Kadakia MP . Identification of vitamin D receptor as a target of p63. Oncogene 2006; 25: 3745–51.
Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, et al. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 2006; 66: 4574–83.
Saramaki A, Banwell CM, Campbell MJ, Carlberg C . Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 2006; 34: 543–54.
Zinser GM, McEleney K, Welsh J . Characterization of mammary tumor cell lines from wild type and vitamin D(3) receptor knockout mice. Mol Cell Endocrinol 2003; 200: 67–80.
Flanagan L, Packman K, Juba B, O'Neill S, Tenniswood M, Welsh J . Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J Steroid Biochem Mol Biol 2003; 84: 181–92.
James SY, Mercer E, Brady M, Binderup L, Colston KW . EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol 1998; 125: 953–62.
VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J . Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology 1998; 139: 2102–10.
Eisman JA, Macintyre I, Martin TJ, Frampton RJ, King RJ . Normal and malignant breast tissue is a target organ for 1,25-(OH)2 vitamin D3. Clin Endocrinol 1980; 13: 267–72.
Zinser G, Packman K, Welsh J . Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 2002; 129: 3067–76.
Zinser GM, Welsh J . Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol 2004; 18: 2208–23.
Rowling MJ, Kemmis CM, Taffany DA, Welsh J . Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr 2006; 136: 2754–9.
Lipkin M, Newmark HL . Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 1999; 18: 392S–7S.
Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, et al. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst 1997; 89: 212–18.
Bernardi RJ, Johnson CS, Modzelewski RA, Trump DL . Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells. Endocrinology 2002; 143: 2508–14.
El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, et al. The vitamin D analogue EB1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 2000; 60: 4412–8.
Zinser GM, Suckow M, Welsh J . Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol 2005; 97: 153–64.
Zinser GM, Welsh J . Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 2004; 25: 2361–72.
Zinser GM, Sundberg JP, Welsh J . Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 2002; 23: 2103–9.
Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R . Resistance of HBL100 human breast epithelial cells to vitamin D action. Carcinogenesis 1999; 20: 577–82.
Solomon C, Kremer R, White JH, Rhim JS . Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies. Radiat Res 2001; 155: 156–62.
Hansen CM, Rohde L, Madsen MW, Hansen D, Colston KW, Pirianov G, et al. MCF-7/VD(R): a new vitamin D resistant cell line. J Cell Biochem 2001; 82: 422–36.
Narvaez CJ, Vanweelden K, Byrne I, Welsh J . Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology 1996; 137: 400–9.
Byrne B, Welsh J . Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. J Steroid Biochem Mol Biol 2007; 103: 703–7.
Narvaez CJ, Byrne BM, Romu S, Valrance M, Welsh J . Induction of apoptosis by 1,25-dihydroxyvitamin D(3) in MCF-7 Vitamin D(3)-resistant variant can be sensitized by TPA. J Steroid Biochem Mol Biol 2003; 84: 199–209.
Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000; 25: 144–6.
Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ . Epigenetic corruption of VDR signalling in malignancy. Anti-cancer Res 2006; 26: 2557–66.
Banwell CM, MacCartney D P, Guy M, Miles AE, Uskokovic MR, Mansi J, et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res 2006; 12: 2004–13.
Knekt P, Jarvinen R, Seppanen R, Pukkala E, Aromaa A . Intake of dairy products and the risk of breast cancer. Br J Cancer 1996; 73: 687–91.
John EM, Schwartz GG, Dreon DM, Koo J . Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999; 8: 399–406.
Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM . Intakes of calcium and vitamin d and breast cancer risk in women. Arch Intern Med 2007; 167: 1050–9.
Berube S, Diorio C, Verhoek-Oftedahl W, Brisson J . Vitamin D, calcium and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004; 13: 1466–72.
Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B . Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev 2007; 16: 929–33.
Giovannucci E . The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16: 83–95.
Grant WB, Garland CF . The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26: 2687–99.
Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007; 103: 708–11.
Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000; 247: 260–8.
Hart GR, Furniss JL, Laurie D, Durham SK . Measurement of vitamin D status: background, clinical use, and methodologies. Clin Lab 2006; 52: 335–43.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported by grants from the NIH (CA69700, CA103018, CA101114), the Department of Defense Breast Cancer Research Program (DAMD17-03-1-0358, DAMD17-03-1-0359) and the Susan G Komen Foundation (PDF0403052).
Rights and permissions
About this article
Cite this article
Welsh, J. Vitamin D and prevention of breast cancer. Acta Pharmacol Sin 28, 1373–1382 (2007). https://doi.org/10.1111/j.1745-7254.2007.00700.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00700.x
Keywords
This article is cited by
-
Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
npj Breast Cancer (2017)
-
Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer
Journal of Cancer Research and Clinical Oncology (2017)
-
Environmental Exposure and Tumor Heterogeneity in Colorectal Cancer Risk and Outcomes
Current Colorectal Cancer Reports (2014)
-
Distinct nuclear receptor expression in stroma adjacent to breast tumors
Breast Cancer Research and Treatment (2013)
-
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study
Breast Cancer Research (2012)